| Popis: |
The effectiveness of TC therapy, a non-anthracycline regimen, was determined through the US Oncology 9735 trial, which was conducted overseas. This led to high expectations regarding the use of TC therapy as a postoperative adjuvant treatment for early-stage breast cancer. We studied 38 patients with breast cancer who underwent TC treatment in our department between August 2008 and November 2009, and discussed the development of side effects in the patients. Continuation of TC therapy on an outpatient basis was considered possible if exanthema and edema were adequately managed. |
